Breast Lumps Screening-Genetic Studies and Immunocytochemistry

1
Last Updated on Oct 25, 2018
Average
4
Rating : 12345
Rate This Article : 1 2 3 4 5
RSS Email Print This Page Comment bookmark
Font : A-A+

Genetic Studies & Immuno-cytochemistry

Finding BRCA gene mutation increases the risk of developing breast cancer especially if there is a family histroy of the cancer.

Approximately 10% of the 1,92,000 women who have breast cancer have hereditary form of the disease.

BRCA1 and BRCA2 are protective genes that help in ensuring that the cells do not turn malignant ( called tumor suppressor genes) and are found in every one. A mutation or alteration in these genes increases the risk of developing breast cancer especially in families with multiple cases of breast and ovarian cancer. A woman with any of these mutations could develop the cancer rather young in life.

However it is not mandatory that a woman who belongs to a high risk family would carry the mutated genes neither is it mandatory for a woman who carries these BRCA mutations to actually develop the cancer.

Men too, with BRCA mutations, are a greater risk of developing breast cancer.

BRCA mutations are detected by analyzing the DNA through special studies (called Polymerase Chain Reaction or PCR) .

A person who tests positive for any BRCA mutation has to be continually monitored through physical breast exam and mammograms. To minimize their risks of developing cancer they should also avoid additional triggering factors such as alcohol or drugs and also adopt a healthy lifestyle.

Some people who have tested positive chose to have preventive surgeries such as prophylactic mastectomy or removal of their ovaries (salpingo-oophorectomy). For some individuals preventive chemotherapy is the method of choice.

Approximately two thirds of breast cancers in post menopausal women are

  • Estrogen receptor positive (ER+)
  • Progesterone receptor positive (PR+)

In normal cells, HER2 is a cell-surface protein involved in cell growth and division. In cancer cells this protein gets activated resulting in tumor formation. In about 20-30% of individuals with breast cancer, HER2 is overexpressed.

It is recommended that all breast cancers are screened for estrogen and progesterone receptors and HER2.

Post a Comment

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
Notify me when reply is posted
I agree to the terms and conditions

But it has been noticed that - all the leisons not detected -some time no detection in M-gram but small detection in Ultrasoound - but time consuming .So based on the negative mamogram -can ?we afford the patient to go escort free -

Premium Membership Benefits

Health Topics A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Medindia Health Topics Search

Breast Cancer

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Doctor Search

Stay Connected

  • Available on the Android Market
  • Available on the App Store